What Researchers Did
Researchers designed a study to test if hyperbaric oxygen therapy (HBOT) can reduce chronic neurobehavioral symptoms in US veterans and service members with mild to moderate traumatic brain injury (TBI), compared to a sham treatment.
What They Found
This study protocol details a plan to enroll 420 US veterans and service members with chronic mild to moderate TBI. Participants will receive either hyperbaric oxygen therapy at 2.0 Atmospheres Absolute (ATA) or a sham treatment at 1.0 ATA, both for approximately 60 minutes. The main goal is to assess changes in Neurobehavioral Symptom Inventory (NSI) scores, with secondary goals including the number of HBOT sessions needed and the impact on PTSD symptoms.
What This Means for Canadian Patients
If this study demonstrates that HBOT is effective, it could offer a new potential treatment option for Canadian patients experiencing chronic neurobehavioral symptoms from mild to moderate traumatic brain injury. This research could help address a significant unmet need for effective therapies for TBI in Canada.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a study protocol, this research has not yet yielded results, and its findings will be based on data from a single study center.